Health News People 50 And Older Should Get Pneumococcal Vaccine, U S Health Officials Recommend
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Health News People 50 And Older Should Get Pneumococcal Vaccine, U S Health Officials Recommend is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
People 50 and older should get pneumococcal vaccine, CDC recommends

U.S. health officials on Wednesday recommended that people 50 and older get a shot against bacteria that can cause pneumonia and other dangerous illnesses. The recommendation was made by a scientific ... Read More
How to Get the Vaccines You Need Now
Learn how to get the vaccines you need now to protect yourself from illnesses, including flu, RSV, measles, Covid-19, and others ... Read More
Study provides more positive data on adult pneumococcal vaccine
Findings from a phase 3 study provided additional evidence that the first pneumococcal vaccine made specifically for adults is well tolerated and provides strong protection for patients at an ... Read More
Dr. Stephen Jumic: Should you get a pneumococcal vaccine?

Dr. Stephen Jumic, hospital medicine at Northwestern Medicine Palos Hospital, joins Wendy Snyder, filling in for John Williams, to talk about flu cases increasing, how dangerous the flu can be, the ... Read More
Manipal Bengaluru pulmonologist warns pneumococcal infections are a silent threat for adults over 50

Pneumococcal disease is often underestimated, but for adults with underlying health conditions or weakened immunity, it can be life-threatening. Despite vaccines being available, many at-risk adults ... Read More
As vaccines industry struggles, Merck's adult pneumococcal shot Capvaxive off to strong start

With vaccine sales on the decline across the industry, these are tough times for Merck to launch its new pneumococcal shot Capvaxive. But in the third quarter, the company recorded encouraging sales ... Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus

